A natural propenoic acid derivative activates peroxisome proliferator-activated receptor-β/δ (PPARβ/δ)

Life Sciences

Volumn 86, Issue 13-14, 2010, Pages 493-498

  Genovese, Salvatore ^a   Foreman, Jennifer E ^b   Borland, Michael G ^b   Epifano, Francesco ^a   Gonzalez, Frank J ^d   Curini, Massimo ^c   Peters, Jeffrey M ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PERUGIA   (Italy)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Cell proliferation; Natural ligand; Peroxisome proliferator activated receptor

Indexed keywords

4' GERANYLOXY DIHYDRO PARA COUMARIC ACID; 4' GERANYLOXY PARA COUMARIC ACID; 4' GERANYLOXYFERULIC ACID; 4' ISOPENTENYLOXY DIHYDRO PARA COUMARIC ACID; 4' ISOPENTENYLOXY PARA COUMARIC ACID; ACRYLIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT; BOROPINIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; UNCLASSIFIED DRUG; AURAPTENE; COUMARIN DERIVATIVE; PHENYLPROPIONIC ACID DERIVATIVE;

ANIMAL CELL; ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; STRUCTURE ACTIVITY RELATION; WILD TYPE; ANIMAL; CELL LINE; CELL STRAIN COS1; CERCOPITHECUS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; TUMOR CELL LINE; UPREGULATION;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; COS CELLS; COUMARINS; GENE EXPRESSION REGULATION; HUMANS; MICE; MOLECULAR STRUCTURE; PHENYLPROPIONATES; POLYMERASE CHAIN REACTION; PPAR DELTA; PPAR-BETA; UP-REGULATION;

EID: 77950558342     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.02.008     Document Type: Article

References (32)

1. Barish G.D., Narkar V.A., Evans R.M. PPARδ: a dagger in the heart of the metabolic syndrome. Journal of Clinical Investigation 2006, 116:590-597.
2. Bility M., Thompson J.T., McKee R.H., David R.M., Butala J.H., Vanden Heuvel J.P., Peters J.M. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters. Toxicological Sciences 2004, 82:170-182.
3. Borland M.G., Foreman J.E., Girroir E.E., Zolfaghari R., Sharma A.K., Amin S.M., Gonzalez F.J., Ross A.C., Peters J.M. Ligand activation of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) inhibits cell proliferation in human HaCaT keratinocytes. Molecular Pharmacology 2008, 74:1429-1442.
4. Burdick A.D., Bility M.T., Girroir E.E., Billin A.N., Willson T.M., Gonzalez F.J., Peters J.M. Ligand activation of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) inhibits cell growth of human N/TERT-1 keratinocytes. Cellular Signalling 2007, 19:1163-1171.
5. Chong H.C., Tan M.J., Philippe V., Tan S.H., Tan C.K., Ku C.W., Goh Y.Y., Wahli W., Michalik L., Tan N.S. Regulation of epithelial-mesenchymal IL-1 signaling by PPARβ/δ is essential for skin homeostasis and wound healing. Journal of Cell Biology 2009, 184:817-831.
6. Curini M., Epifano F., Genovese S., Marcotullio M.C., Menghini L. 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid: a novel promising cancer chemopreventive agent. Anti-cancer Agents in Medical Chemistry 2006, 6:571-577.
7. Epifano F., Genovese S., Menghini L., Curini M. Chemistry and pharmacology of oxyprenylated secondary plant metabolites. Phytochemistry 2007, 68:939-953.
8. Evans R.M., Barish G.D., Wang Y.X. PPARs and the complex journey to obesity. Nature Medicine 2004, 10:355-361.
9. Forman B.M., Chen J., Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and delta;. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:4312-4317.
10. Genovese S., Epifano F., Curini M., Dudra-Jastrzebska M., Luszczki J.J. Prenyloxyphenylpropanoids as a novel class of anticonvulsive agents. Bioorganic & Medicinal Chemistry Letters 2009, 19:5419-5422.
11. Girroir E.E., Hollingshead H.E., He P., Zhu B., Perdew G.H., Peters J.M. Quantitative expression patterns of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) protein in mice. Biochemical and Biophysical Research Communications 2008, 371:456-461.
12. Harman F.S., Nicol C.J., Marin H.E., Ward J.M., Gonzalez F.J., Peters J.M. Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis. Nature Medicine 2004, 10:481-483.
13. Hollingshead H.E., Borland M.G., Billin A.N., Willson T.M., Gonzalez F.J., Peters J.M. Ligand activation of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms. Carcinogenesis 2008, 29:169-176.
14. Kilgore K.S., Billin A.N. PPARβ/δ ligands as modulators of the inflammatory response. Current Opinion in Investigational Drugs 2008, 9:463-469.
15. Kim D.J., Akiyama T.E., Harman F.S., Burns A.M., Shan W., Ward J.M., Kennett M.J., Gonzalez F.J., Peters J.M. Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis. Journal of Biological Chemistry 2004, 279:23719-23727.
16. Kim D.J., Murray I.A., Burns A.M., Gonzalez F.J., Perdew G.H., Peters J.M. Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) inhibits epidermal cell proliferation by down-regulation of kinase activity. Journal of Biological Chemistry 2005, 280:9519-9527.
17. Kim D.J., Bility M.T., Billin A.N., Willson T.M., Gonzalez F.J., Peters J.M. PPARβ/δ selectively induces differentiation and inhibits cell proliferation. Cell Death and Differentiation 2006, 13:53-60.
18. Kippenberger S., Loitsch S.M., Grundmann-Kollmann M., Simon S., Dang T.A., Hardt-Weinelt K., Kaufmann R., Bernd A. Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation. Journal of Investigative Dermatology 2001, 117:1430-1436.
19. Kuroyanagi K., Kang M.S., Goto T., Hirai S., Ohyama K., Kusudo T., Yu R., Yano M., Sasaki T., Takahashi N., Kawada T. Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 2008, 366:219-225.
20. Lee C.H., Olson P., Evans R.M. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 2003, 144:2201-2207.
21. Man M.Q., Barish G.D., Schmuth M., Crumrine D., Barak Y., Chang S., Jiang Y., Evans R.M., Elias P.M., Feingold K.R. Deficiency of PPARβ/δ in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation. Journal of Investigative Dermatology 2007, 128:370-377.
22. Marin H.E., Peraza M.A., Billin A.N., Willson T.M., Ward J.M., Kennett M.J., Gonzalez F.J., Peters J.M. Ligand activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) inhibits colon carcinogenesis. Cancer Research 2006, 66:4394-4401.
23. Michalik L., Desvergne B., Tan N.S., Basu-Modak S., Escher P., Rieusset J., Peters J.M., Kaya G., Gonzalez F.J., Zakany J., Metzger D., Chambon P., Duboule D., Wahli W. Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)α and PPARβ mutant mice. Journal of Cell Biology 2001, 154:799-814.
24. Michalik L., Desvergne B., Wahli W. Peroxisome-proliferator-activated receptors and cancers: complex stories. Nature Reviews. Cancer 2004, 4:61-70.
25. O'Sullivan S.E. Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. British Journal of Pharmacology 2007, 152:576-582.
26. Peraza M.A., Burdick A.D., Marin H.E., Gonzalez F.J., Peters J.M. The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicological Sciences 2006, 90:269-295.
27. Peters J.M., Gonzalez F.J. Sorting out the functional role(s) of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in cell proliferation and cancer. Biochimica et Biophysica Acta 2009, 1796:230-241.
28. Peters J.M., Lee S.S.T., Li W., Ward J.M., Gavrilova O., Everett C., Reitman M.L., Hudson L.D., Gonzalez F.J. Growth, adipose, brain and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β/δ. Molecular and Cellular Biology 2000, 20:5119-5128.
29. Peters J.M., Cheung C., Gonzalez F.J. Peroxisome proliferator-activated receptor-α and liver cancer: where do we stand?. Journal of Molecular Medecine 2005, 83:774-785.
30. Peters J.M., Hollingshead H.E., Gonzalez F.J. Role of peroxisome-proliferator-activated receptor β/δ (PPARβ/δ) in gastrointestinal tract function and disease. Clinical Science (London) 2008, 115:107-127.
31. Takahashi N., Kang M.S., Kuroyanagi K., Goto T., Hirai S., Ohyama K., Lee J.Y., Yu R., Yano M., Sasaki T., Murakami S., Kawada T. Auraptene, a citrus fruit compound, regulates gene expression as a PPARalpha agonist in HepG2 hepatocytes. Biofactors 2008, 33:25-32.
32. Tanaka T., de Azevedo M.B., Duran N., Alderete J.B., Epifano F., Genovese S., Tanaka M., Curini M. Colorectal cancer chemoprevention by two beta-cyclodextrin inclusion compounds of auraptene and 4'-geranyloxyferulic acid. International Journal of Cancer 2010, 126:830-840.